Top Institutions in Breast Cancer Genomic Testing
Leading institutions conduct large-scale clinical trials, such as MINDACT, and integrate genomic profiling into clinical practice guidelines. They combine expertise in molecular oncology, pathology, and clinical trials to validate genomic assays and translate findings into personalized treatment strategies.
-
#1
Dana-Farber Cancer Institute
Boston, MA
Dana-Farber is a pioneer in breast cancer research and genomic testing, leading major trials such as MINDACT and integrating genomic assays into clinical decision-making.
Key Differentiators
- Breast Oncology
- Genomic Medicine
- Clinical Trials
-
#2
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC has robust programs in molecular profiling and personalized oncology, contributing to the development and clinical implementation of genomic tests in breast cancer.
Key Differentiators
- Breast Cancer Surgery
- Molecular Oncology
- Genomic Profiling
-
#3
MD Anderson Cancer Center
Houston, TX
MD Anderson is recognized for its leadership in breast cancer genomics and personalized therapy, including studies on genomic predictors of chemotherapy benefit.
Key Differentiators
- Breast Cancer Research
- Genomic Medicine
- Clinical Trials
-
#4
Johns Hopkins Medicine
Baltimore, MD
Johns Hopkins excels in molecular pathology and translational research, advancing understanding of tumor biology and genomic assay development in breast cancer.
Key Differentiators
- Molecular Pathology
- Breast Cancer Genomics
- Translational Research
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in breast cancer clinical research and genomic medicine, focusing on personalized treatment strategies and emerging therapies informed by genomic testing.
Key Differentiators
- Breast Oncology
- Genomic Medicine
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
